MRVI Maravai LifeSciences Holdings, Inc.
Healthcare$4.38-0.45%ClosedMarket Cap: $1.21B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.05
P/S
5.94
EV/EBITDA
-10.78
DCF Value
$2.42
FCF Yield
-4.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.0%
Operating Margin
21.9%
Net Margin
-51.1%
ROE
-44.7%
ROA
-14.7%
ROIC
6.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $65.8M | 51.2% | $2.5M | $-3.7M | $— | — |
| Q4 null | $49.9M | 24.5% | $-6.7M | $-35.7M | $— | — |
| FY null | $185.7M | 18.0% | $-6.7M | $-130.8M | $— | — |
| Q3 null | $41.6M | 13.6% | $115.4M | $-25.6M | $— | — |
| Q2 null | $47.4M | 16.4% | $-66.3M | $-39.6M | $— | — |
| Q1 null | $46.9M | 16.5% | $-49.2M | $-29.9M | $— | — |
| Q4 null | $56.4M | 33.6% | $-38.1M | $-26.1M | $— | — |
| FY null | $259.2M | 41.8% | $-235.6M | $-144.8M | $— | — |
| Q3 null | $65.2M | 43.5% | $-169.1M | $-99.0M | $— | — |
| Q2 null | $73.4M | 47.9% | $-9.5M | $-7.6M | $— | — |
| Q1 null | $64.2M | 40.3% | $-18.9M | $-12.1M | $— | — |
| Q4 2023 | $74.1M | 52.6% | $-7.2M | $-106.0M | $-0.80 | — |